Mycoplasma genitalium: Should we treat and how?

Clinical Infectious Diseases

Volumn 53, Issue SUPPL. 3, 2011, Pages

  Manhart, Lisa E ^a   Broad, Jennifer M ^a   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFOXITIN; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LYMECYCLINE; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; OFLOXACIN; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFALAZIL; SPECTINOMYCIN; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM DETECTION; CLINICAL FEATURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TREATMENT FAILURE; ECTOPIC PREGNANCY; FEMALE INFERTILITY; HUMAN; MYCOPLASMA GENITALIUM; MYCOPLASMOSIS; NONHUMAN; PELVIC INFLAMMATORY DISEASE; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PRIORITY JOURNAL; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URETHRITIS; UTERINE CERVICITIS;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; AZITHROMYCIN; DOXYCYCLINE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFERTILITY, FEMALE; MALE; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; QUINOLINES; TREATMENT OUTCOME; URETHRITIS; UTERINE CERVICITIS;

EID: 81055147592     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir702     Document Type: Article

References (116)

1. Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981; 1:1288-91. (Pubitemid 11111354)
2. Fraser CM, Gocayne JD, White O, et al. The minimal gene complement of Mycoplasma genitalium. Science 1995; 270:397-403.
3. Gibson DG, Benders GA, Andrews-Pfannkoch C, et al. Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 2008; 319:1215-20. (Pubitemid 351323011)
4. Jensen JS, Uldum SA, Sondergard-Andersen J, Vuust J, Lind K. Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples. J Clin Microbiol 1991; 29:46-50.
5. Palmer HM, Gilroy CB, Furr PM, Taylor-Robinson D. Development and evaluation of the polymerase chain reaction to detect Mycoplasma genitalium. FEMS Microbiol Lett 1991; 61:199-203.
6. Horner PJ, Gilroy CB, Thomas BJ, Naidoo RO, Taylor-Robinson D. Association of Mycoplasma genitalium with acute non-gonococcal urethritis. Lancet 1993; 342:582-5. (Pubitemid 23259235)
7. Jensen JS, Orsum R, Dohn B, Uldum S,Worm AM, Lind K. Mycoplasma genitalium: a cause of male urethritis? Genitourin Med 1993; 69:265-9. (Pubitemid 23244015)
8. Janier M, Lassau F, Casin I, et al. Male urethritis with and without discharge: a clinical and microbiological study. Sex Transm Dis 1995; 22:244-52.
9. Deguchi T, Komeda H, Yasuda M, et al. Mycoplasma genitalium in non-gonococcal urethritis. Int J STD AIDS 1995; 6:144-5.
10. Busolo F, Camposampiero D, Bordignon G, Bertollo G. Detection of Mycoplasma genitalium and Chlamydia trachomatis DNAs in male patients with urethritis using the polymerase chain reaction. New Microbiol 1997; 20:325-32. (Pubitemid 127527563)
11. Maeda S, Tamaki M, Nakano M, Uno M, Deguchi T, Kawada Y. Detection of Mycoplasma genitalium in patients with urethritis. J Urol 1998; 159:405-7. (Pubitemid 28049242)
12. Gambini D, Decleva I, Lupica L, Ghislanzoni M, Cusini M, Alessi E. Mycoplasma genitalium in males with nongonococcal urethritis: prevalence and clinical efficacy of eradication. Sex Transm Dis 2000; 27:226-9. (Pubitemid 30210801)
13. Johannisson G, Enstrom Y, Lowhagen GB, et al. Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden. Int J STD AIDS 2000; 11:324-6. (Pubitemid 30245746)
14. Keane FE, Thomas BJ, Gilroy CB, Renton A, Taylor-Robinson D. The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners. Int J STD AIDS 2000; 11:356-60. (Pubitemid 30352681)
15. Björnelius E, Lidbrink P, Jensen JS. Mycoplasma genitalium in nongonococcal urethritis-a study in Swedish male STD patients. Int J STD AIDS 2000; 11:292-6. (Pubitemid 30245742)
16. Horner P, Thomas B, Gilroy CB, Egger M, Taylor-Robinson D. Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis. Clin Infect Dis 2001; 32:995-1003. (Pubitemid 32299633)
17. Totten PA, Schwartz MA, Sjostrom KE, et al. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001; 183:269-76. (Pubitemid 32066029)
18. Mena L, Wang X, Mroczkowski TF, Martin DH. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis 2002; 35:1167-73. (Pubitemid 35305864)
19. Yoshida T, Deguchi T, Ito M, Maeda S, Tamaki M, Ishiko H. Quantitative detection of Mycoplasma genitalium from first-pass urine of men with urethritis and asymptomatic men by real-time PCR. J Clin Microbiol 2002; 40:1451-5. (Pubitemid 34279916)
20. Dupin N, Bijaoui G, Schwarzinger M, et al. Detection and quantification of Mycoplasma genitalium in male patients with urethritis. Clin Infect Dis 2003; 37:602-5. (Pubitemid 37011787)
21. Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect 2004; 80:289-93. (Pubitemid 39089102)
22. Iser P, Read TH, Tabrizi S, et al. Symptoms of non-gonococcal urethritis in heterosexual men: a case control study. Sex Transm Infect 2005; 81:163-5. (Pubitemid 40523831)
23. Anagrius C, Lore B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81: 458-62. (Pubitemid 41811325)
24. Bradshaw CS, Tabrizi SN, Read TR, et al. Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure. J Infect Dis 2006; 193:336-45. (Pubitemid 43122332)
25. Leung A, Eastick K, Haddon LE, Horn CK, Ahuja D, Horner PJ. Mycoplasma genitalium is associated with symptomatic urethritis. Int J STD AIDS 2006; 17:285-8. (Pubitemid 43668164)
26. Yu JT, Tang WY, Lau KH, Chong LY, Lo KK. Asymptomatic urethral infection in male sexually transmitted disease clinic attendees. Int J STD AIDS 2008; 19:155-8. (Pubitemid 351738789)
27. Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium is associated with symptomatic and asymptomatic non-gonococcal urethritis in men. Sex Transm Infect 2009; 85:15-8.
28. Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics. Sex Transm Infect 2009; 85:438-40.
29. Soni S, Alexander S, Verlander N, et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect 2010; 86:21-4.
30. Taylor-Robinson D, Renton A, Jensen JS, et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD AIDS 2009; 20:234-7.
31. Couldwell DL, Gidding HF, Freedman EV, et al. Ureaplasma urealyticum is significantly associated with non-gonococcal urethritis in heterosexual Sydney men. Int J STD AIDS 2010; 21:337-41.
32. Berntsson M, Lowhagen GB, Bergstrom T, et al. Viral and bacterial aetiologies of male urethritis: findings of a high prevalence of Epstein-Barr virus. Int J STD AIDS 2010; 21:191-4.
33. Hilton J, Azariah S, Reid M. A case-control study of men with nongonococcal urethritis at Auckland Sexual Health Service: rates of detection of Mycoplasma genitalium. Sex Health 2010; 7:77-81.
34. Pepin J, Sobela F, Deslandes S, et al. Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalis. Bull World Health Organ 2001; 79:118-26. (Pubitemid 32187792)
35. Taylor-Robinson D, Jensen JS, Fehler G, Radebe F, Ballard RC. Observations on the microbiology of urethritis in black South African men. Int J STD AIDS 2002; 13:323-5. (Pubitemid 34492968)
36. Sturm PD, Moodley P, Khan N, et al. Aetiology of male urethritis in patients recruited from a population with a high HIV prevalence. Int J Antimicrob Agents 2004; 24(Suppl 1):S8-14. (Pubitemid 39208853)
37. Black V, Magooa P, Radebe F, Myers M, Pillay C, Lewis DA. The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa's syndromic management approach be revised? Sex Transm Infect 2008; 84:254-8.
38. Morency P, Dubois MJ, Gresenguet G, et al. Aetiology of urethral discharge in Bangui, Central African Republic. Sex Transm Infect 2001; 77:125-9.
39. Luo D, Zhu W, Zhang X, et al. Molecular epidemiologic study of Mycoplasma genitalium infection in high risk populations of sexually transmitted diseases in China. Chin Med J (Engl) 2000; 113:1015-8.
40. Maeda SI, Tamaki M, Kojima K, et al. Association of Mycoplasma genitalium persistence in the urethra with recurrence of nongonococcal urethritis. Sex Transm Dis 2001; 28:472-6. (Pubitemid 32730296)
41. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006; 12:1149-52. (Pubitemid 44061291)
42. Stamm WE, Batteiger BE, McCormack WM, Totten PA, Sternlicht A, Kivel NM. A randomized, double-blind study comparing singledose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men. Sex Transm Dis 2007; 34:542-52.
43. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008; 3:e3618.
44. Björnelius E, Anagrius C, Bojs G, et al. Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial. Sex Transm Infect 2008; 84:72-6. (Pubitemid 351195859)
45. Mena LA, Mroczkowski TF, Malanda N, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium positive urethritis in men. Clin Infect Dis 2009; 48:1649-54.
46. Casin I, Vexiau-Robert D, De La Salmoniere P, Eche A, Grandry B, Janier M. High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France. Sex Transm Dis 2002; 29:353-9. (Pubitemid 34600984)
47. Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:73-8. (Pubitemid 40222871)
48. Hogdahl M, Kihlstrom E. Leucocyte esterase testing of firstvoided urine and urethral and cervical smears to identify Mycoplasma genitalium-infected men and women. Int J STD AIDS 2007; 18:835-8. (Pubitemid 351738864)
49. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Hobbs MM. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35:250-4. (Pubitemid 351619518)
50. Korte JE, Baseman JB, Cagle MP, et al. Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 2006; 55:265-75. (Pubitemid 43349262)
51. Hooton TM, Roberts MC, Roberts PL, Holmes KK, Stamm WE, Kenny GE. Prevalence of Mycoplasma genitalium determined by DNA probe in men with urethritis. Lancet 1988; 1:266-8. (Pubitemid 18052261)
52. Taylor-Robinson D, Gilroy CB, Thomas BJ, Hay PE. Mycoplasma genitalium in chronic non-gonococcal urethritis. Int J STD AIDS 2004; 15:21-5. (Pubitemid 38096124)
53. Wikstrom A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006; 82:276-9. (Pubitemid 44229437)
54. Gaydos C, Maldeis NE, Hardick A, Hardick J, Quinn TC. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 2009; 36:598-606.
55. Manhart LE, Critchlow CW, Holmes KK, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187:650-7. (Pubitemid 36250029)
56. Pepin J, Labbe AC, Khonde N, et al. Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers. Sex Transm Infect 2005; 81:67-72. (Pubitemid 40222870)
57. Pepin J, Sobela F, Khonde N, et al. The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa. Bull World Health Organ 2006; 84:729-38. (Pubitemid 44482399)
58. Uno M, Deguchi T, Komeda H, et al. Mycoplasma genitalium in the cervices of Japanese women. Sex Transm Dis 1997; 24:284-6. (Pubitemid 27208980)
59. Palmer HM, Gilroy CB, Claydon EJ, Taylor-Robinson D. Detection of Mycoplasma genitalium in the genitourinary tract of women by the polymerase chain reaction. Int J STD AIDS 1991; 2:261-3.
60. Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 2009; 85: 10-4.
61. Lusk MJ, Konecny P, Naing ZW, Garden FL, Cumming RG, RawlinsonWD. Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect 2011; 87:107-9.
62. Moller BR, Taylor-Robinson D, Furr PM. Serological evidence implicating Mycoplasma genitalium in pelvic inflammatory disease. Lancet 1984; 1:1102-3. (Pubitemid 14100810)
63. Lind K, Kristensen GB. Significance of antibodies to Mycoplasma genitalium in salpingitis. Eur J Clin Microbiol 1987; 6:205-7. (Pubitemid 17066127)
64. Jurstrand M, Jensen JS, Magnuson A, Kamwendo F, Fredlund H. A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy. Sex Transm Infect 2007; 83:319-23. (Pubitemid 47242512)
65. Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359:765-6. (Pubitemid 34215080)
66. Simms I, Eastick K, Mallinson H, et al. Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Sex Transm Infect 2003; 79:154-6. (Pubitemid 36469624)
67. Cohen CR, Mugo NR, Astete SG, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 2005; 81:463-6. (Pubitemid 41811326)
68. Haggerty CL, Totten PA, Astete SG, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 2008; 84:338-42.
69. Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG; 117:361-4.
70. Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in women the "new chlamydia?" A community-based prospective cohort study. Clin Infect Dis 2010; 51:1160-6.
71. Wiesenfeld HC, Martin DH, Mancuso M, Hillier SL, Amortegui A, Sweet RL. The association between Mycoplasma genitalium and subclinical pelvic inflammatory disease. London, United Kingdom: International Society for Sexually Transmitted Disease Reseach (ISSTDR), 2009: Abstract #P3.36.
72. Moller BR, Taylor-Robinson D, Furr PM, Freundt EA. Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium. Br J Exp Pathol 1985; 66:417-26. (Pubitemid 15247873)
73. Moller BR, Taylor-Robinson D, Furr PM, Toft B, Allen J. Serological evidence that chlamydiae and mycoplasmas are involved in infertility of women. J Reprod Fertil 1985; 73:237-40. (Pubitemid 15150590)
74. Clausen HF, Fedder J, Drasbek M, et al. Serological investigation of Mycoplasma genitalium in infertile women. Hum Reprod 2001; 16:1866-74. (Pubitemid 32916214)
75. Svenstrup HF, Fedder J, Kristoffersen SE, Trolle B, Birkelund S, Christiansen G. Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility-a prospective study. Fertil Steril 2008; 90: 513-20.
76. Grzesko J, Elias M, Maczynska B, Kasprzykowska U, Tlaczala M, Goluda M. Occurrence of Mycoplasma genitalium in fertile and infertile women. Fertil Steril 2009; 91:2376-80.
77. Kjaergaard N, Kristensen B, Hansen ES, et al. Microbiology of semen specimens from males attending a fertility clinic. APMIS 1997; 105: 566-70. (Pubitemid 27323138)
78. Gdoura R, Kchaou W, Chaari C, et al. Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis and Mycoplasma genitalium infections and semen quality of infertile men. BMC Infect Dis 2007; 7:129.
79. Gdoura R, Kchaou W, Ammar-Keskes L, et al. Assessment of Chlamydia trachomatis, Ureaplasma urealyticum, Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium in semen and first void urine specimens of asymptomatic male partners of infertile couples. J Androl 2008; 29:198-206. (Pubitemid 351345717)
80. Labbe AC, Frost E, Deslandes S, Mendonca AP, Alves AC, Pepin J. Mycoplasma genitalium is not associated with adverse outcomes of pregnancy in Guinea-Bissau. Sex Transm Infect 2002; 78:289-91.
81. Oakeshott P, Hay P, Taylor-Robinson D, et al. Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome. BJOG 2004; 111:1464-7. (Pubitemid 39665043)
82. Kataoka S, Yamada T, Chou K, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol 2006; 44:51-5. (Pubitemid 43100578)
83. Edwards RK, Ferguson RJ, Reyes L, Brown M, Theriaque DW, Duff P. Assessing the relationship between preterm delivery and various microorganisms recovered from the lower genital tract. J Matern Fetal Neonatal Med 2006; 19:357-63. (Pubitemid 43995618)
84. Hitti J, Garcia P, Totten P, Paul K, Astete S, Holmes KK. Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women. Sex Transm Dis 2010; 37:81-5.
85. Falk L, Fredlund H, Jensen JS. Tetracycline treatment does not eradicate Mycoplasma genitalium. Sex Transm Infect 2003; 79:318-9. (Pubitemid 37026351)
86. Schwebke JR, Rompalo A, Taylor S, et al. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens-a randomized clinical trial. Clin Infect Dis 2011; 52:163-70.
87. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19:676-9.
88. Ross JD, Cronje HS, Paszkowski T, et al. Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial. Sex Transm Infect 2006; 82:446-51. (Pubitemid 46025184)
89. Takahashi S, Ichihara K, Hashimoto J, et al. Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with nongonococcal urethritis. J Infect Chemother 2011; 17:392-6.
90. Hamasuna R, Takahashi S, Kiyota H, et al. Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial. Sex Transm Infect 2011; 87:389-90.
91. Jensen JS, Bradshaw CS, Tabrizi SN, Fairley CK, Hamasuna R. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47:1546-53.
92. Ito S, Shimada Y, Yamaguchi Y, et al. Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin. Sex Transm Infect 2011; 87:412-4.
93. Shimada Y, Deguchi T, Nakane K, et al. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Int J Antimicrob Agents 2010; 36:255-8.
94. Shimada Y, Deguchi T, Nakane K, et al. Macrolide resistanceassociated 23S rRNA mutation in Mycoplasma genitalium, Japan. Emerg Infect Dis 2011; 17:1148-50.
95. Yew HS, Anderson T, Coughlan E, Werno A. Induced macrolide resistance in Mycoplasma genitalium isolates from patients with recurrent nongonococcal urethritis. J Clin Microbiol 2011; 49:1695-6.
96. Jensen JC. Mycoplasma genitalium as an STI-consequences for patient management. London, United Kingdom: International Society for Sexually Transmitted Disease Research (ISSTDR), 2009.
97. Renaudin H, Tully JG, Bebear C. In vitro susceptibilities of Mycoplasma genitalium to antibiotics. Antimicrob Agents Chemother 1992; 36:870-2.
98. Hannan PC. Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro. J Med Microbiol 1998; 47:1115-22. (Pubitemid 28534833)
99. Bebear CM, Renaudin J, Charron A, et al. Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis. Antimicrob Agents Chemother 1999; 43:954-6. (Pubitemid 29165766)
100. Hannan PC, Woodnutt G. In vitro activity of gemifloxacin (SB 265805; LB20304a) against human mycoplasmas. J Antimicrob Chemother 2000; 45:367-9. (Pubitemid 30139248)
101. Bebear CM, Renaudin H, Bryskier A, Bebear C. Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas. Antimicrob Agents Chemother 2000; 44:1980-2. (Pubitemid 30422960)
102. Bebear CM, RenaudinH, Charron A, Gruson D, LefrancoisM, Bebear C. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 2000; 44:2557-60. (Pubitemid 30650917)
103. Duffy LB, Crabb D, Searcey K, Kempf MC. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. J Antimicrob Chemother 2000; 45(Suppl 1): 29-33. (Pubitemid 30195554)
104. Deguchi T, Maeda S, Tamaki M, et al. Analysis of the gyrA and parC genes of Mycoplasma genitalium detected in first-pass urine of men with non-gonococcal urethritis before and after fluoroquinolone treatment. J Antimicrob Chemother 2001; 48:742-4. (Pubitemid 33100328)
105. Pereyre S, Guyot C, Renaudin H, Charron A, Bebear C, Bebear CM. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob Agents Chemother 2004; 48:460-5. (Pubitemid 38141702)
106. Yasuda M, Maeda S, Deguchi T. In vitro activity of fluoroquinolones against Mycoplasma genitalium and their bacteriological efficacy for treatment of M. genitalium-positive nongonococcal urethritis in men. Clin Infect Dis 2005; 41:1357-9. (Pubitemid 41532684)
107. Hamasuna R, Osada Y, Jensen JS. Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5# nuclease real-time PCR. Antimicrob Agents Chemother 2005; 49:4993-8. (Pubitemid 41778911)
108. Waites KB, Crabb DM, Duffy LB. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas. Antimicrob Agents Chemother 2008; 52:3776-8.
109. Bebear CM, de Barbeyrac B, Pereyre S, Renaudin H, Clerc M, Bebear C. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clin Microbiol Infect 2008; 14:801-5.
110. Hamasuna R, Takahashi S, Kiyota H, et al. Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: an open clinical trial. Sex Transm Infect 2011; 87:389-90.
111. Speciale A, Musumeci R, Blandino G, Milazzo I, Caccamo F,Nicoletti G. Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates. Int J Antimicrob Agents 2002; 19:111-8. (Pubitemid 34163297)
112. Malay S, Roblin PM, Reznik T, Kutlin A, Hammerschlag MR. In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. Antimicrob Agents Chemother 2002; 46:517-8. (Pubitemid 34087204)
113. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. In-vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. J Infect Chemother 2002; 8:115-7. (Pubitemid 34456593)
114. Donati M, Rodriguez Fermepin M, Olmo A, D'Apote L, Cevenini R. Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. J Antimicrob Chemother 1999; 43: 825-7. (Pubitemid 29273733)
115. Cohen CR, Nosek M, Meier A, et al. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 2007; 34:274-9. (Pubitemid 46707479)
116. Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006: 30184.